ArticleBMC cardiovascular disorders2025
Treatment strategies and prognosis of complete left bundle branch block after transcatheter closure of ventricular septal defect in pediatrics.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundComplete left bundle branch block (CLBBB) is a serious complication associated with transcatheter closure of perimembranous ventricular septal defect (pmVSD). The aim of the study was to evaluate various treatment strategies and prognosis of CLBBB after transcatheter closure of pmVSD in pediatric patients.
methodsTwenty five pediatric patients with CLBBB after transcatheter closure of pmVSD in our institution were retrospectively reviewed.
resultsOver a median follow-up of 6.7 (1.1–12.8) years, 14 cases were defined as early-onset CLBBB. Seven underwent early surgical device removal withing 1 month, 6 restored normal QRS interval, and 1 reverted to incomplete right bundle branch block. 3 underwent late surgical device removal (after 1 month of CLBBB discovery), 2 of them eventually underwent permanent pacemaker implantation, and 1 restored normal QRS interval. 4 cases received corticosteriod therapy, 2 restored normal QRS interval, 1 reverted to left anterior fascicular block, and 1 died of heart failure. 11 cases were defined as late-onset CLBBB and were given corticosteroid therapy as initial treatment. 2 restored normal QRS interval, 1 underwent surgical device removal and restored normal QRS interval, and 8 had persistent CLBBB (1 underwent cardiac transplantation, 1 underwent permanent pacemaker implantation, 4 had left ventricular enlargement with reduced ejection fraction, 2 maintained normal left ventricular size and function). Compared with patients who did not receive early device removal, patients who underwent early device removal were less likely to experience adverse events [0% (0/8) vs.53% (9/17), P = 0.022]. For patients who only received corticosteroid therapy, patients who were free from adverse events had significantly shorter QRS index [(7.90 ± 0.80) vs. (9.40 ± 1.23) ms/(kg/m2), P = 0.032].
conclusionEarly surgical device removal was associated with favorable prognosis of CLBBB after pmVSD device closure. Corticosteroid therapy might be an alternative treatment strategy for CLBBB with relatively narrow QRS interval.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.